Phyllodes tumours of the breast: a consensus review
Phyllodes tumours constitute an uncommon but complex group of mammary fibroepithelial
lesions. Accurate and reproducible grading of these tumours has long been challenging, …
lesions. Accurate and reproducible grading of these tumours has long been challenging, …
[HTML][HTML] Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review
KL Mooney, LW Bassett, SK Apple - Modern Pathology, 2016 - Elsevier
Optimal management of high-risk breast lesions detected by mammogram yielding atypical
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in situ…
ductal hyperplasia, flat epithelial atypia, atypical lobular hyperplasia, lobular carcinoma in situ…
Interventional breast imaging: current procedures and assessing for concordance with pathology
LW Bassett, MC Mahoney, SK Apple - Radiologic Clinics of North America, 2007 - Elsevier
Minimally invasive breast biopsy procedures performed for suspicious imaging findings
have expanded the role of breast imaging in the management of breast diseases. The first …
have expanded the role of breast imaging in the management of breast diseases. The first …
Higher levels of GATA3 predict better survival in women with breast cancer
The GATA family members are zinc finger transcription factors involved in cell differentiation
and proliferation. GATA3 in particular is necessary for mammary gland maturation, and its …
and proliferation. GATA3 in particular is necessary for mammary gland maturation, and its …
Histopathologic Characteristics Predicting HER‐2/neu Amplification in Breast Cancer
R Prati, SK Apple, J He, JA Gornbein… - The breast …, 2005 - Wiley Online Library
The HER‐2/neu gene is a proto‐oncogene that is amplified in 10–30% of breast cancers.
New drugs for targeted therapy, such as Herceptin, are effective for patients with HER‐2/neu‐…
New drugs for targeted therapy, such as Herceptin, are effective for patients with HER‐2/neu‐…
Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?
CN Burge, HR Chang, SK Apple - The Breast, 2006 - Elsevier
Core biopsies are commonly used in the diagnosis of breast cancer and often are the only
sample for providing prognostic and predictive markers prior to neoadjuvant chemotherapy. …
sample for providing prognostic and predictive markers prior to neoadjuvant chemotherapy. …
Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for …
SK Apple, JR Hecht, DN Lewin, SA Jahromi, WW Grody… - Human pathology, 1999 - Elsevier
The pathobiology of precursor lesions leading to invasive pancreatic adenocarcinoma
remains a controversial area, but knowledge of the mechanisms of tumorigenesis may lead to …
remains a controversial area, but knowledge of the mechanisms of tumorigenesis may lead to …
The impact of atypia/follicular lesion of undetermined significance and repeat fine‐needle aspiration: 5 years before and after implementation of the Bethesda System
…, SL Hirschowitz, PC Fung, SK Apple - Cancer …, 2014 - Wiley Online Library
BACKGROUND Limited studies have examined the impact of the Bethesda System for
Reporting Thyroid Cytopathology (BSRTC) and specifically the category of atypia or follicular …
Reporting Thyroid Cytopathology (BSRTC) and specifically the category of atypia or follicular …
Effect of ischemic time, fixation time, and fixative type on HER2/neu immunohistochemical and fluorescence in situ hybridization results in breast cancer
…, N Rao, DY Lu, SK Apple - American journal of …, 2011 - academic.oup.com
Accurate determination of HER2/neu status in breast carcinoma is essential. Alteration of
preanalytic variables is known to affect HER2/neu results. American Society of Clinical …
preanalytic variables is known to affect HER2/neu results. American Society of Clinical …
Association between HER2, TOP2A, and response to anthracycline-based preoperative chemotherapy in high-risk primary breast cancer
…, C Thomssen, N Harbeck, L Wang, S Apple… - Breast cancer research …, 2010 - Springer
In breast cancer, recent studies suggest that the value of HER2 for predicting response to
anthracycline-based chemotherapy may be more likely related to the concomitant amplification …
anthracycline-based chemotherapy may be more likely related to the concomitant amplification …